Concepedia
Statistics
Publications
30
Citations
2.4K
H-Index
24
Active since
1999
Affiliations
Bristol-Myers Squibb (United States)(Current)
Bristol-Myers Squibb (Germany)
University of North Carolina at Chapel Hill
University of Southern California
Jinan University
Feng Luo is an author at Bristol-Myers Squibb (United States) specializing in medicine, oncology, and pharmacology.
Publications per year
1999–2022
Effect of First-Line Serplulimab vs Placebo Added to Chemotherapy on Survival in Patients With Extensive-Stage Small Cell Lung Cancer
Ying Cheng, Liang Han, Lin Wu et al. · JAMA · 2022 · 456 citations · Full text
Medicine, Oncology, Pharmacology +17
Detection, Characterization, and Inhibition of FGFR–TACC Fusions in IDH Wild-type Glioma
Anna Luisa Di Stefano, Alessandra Fucci, Veroniquè Frattini et al. · Clinical Cancer Research · 2015 · 285 citations
Dasatinib (BMS-354825) Pharmacokinetics and Pharmacodynamic Biomarkers in Animal Models Predict Optimal Clinical Exposure
Feng Luo, Zheng Yang, Amy Camuso et al. · Clinical Cancer Research · 2006 · 149 citations
Medicine, Pharmacokinetics, Pharmacology +13
Ovarian Epithelial Tumor Growth Promotion by Follicle-Stimulating Hormone and Inhibition of the Effect by Luteinizing Hormone
Wenxin Zheng, Jean Lu, Feng Luo et al. · Gynecologic Oncology · 2000 · 139 citations
Medicine, Cancer Biology, Oncology +14
Intestinal Transport of Irinotecan in Caco-2 Cells and MDCK II Cells Overexpressing Efflux Transporters Pgp, cMOAT, and MRP1
Feng Luo, Pankaj V. Paranjpe, Ailan Guo et al. · Drug Metabolism and Disposition · 2002 · 116 citations
1–5 of 30